News

The emergence of multidisciplinary, bold and innovative original research projects carried out by the Institut du Cerveau - ICM’s young talents, thanks to the Bolloré Group support, is the Institut du Cerveau - ICM's Brain Booster Challenge bet.

Several teams of the Institut du Cerveau - ICM are acting together to fight rare and orphan neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, hereditary spastic paraplegias (HSP), ataxias, dystonia...

Grégoire Courtine is Associate Professor at the Swiss Federal Institute of Technology. He came to the Institut du Cerveau - ICM on February 1, 2016, and presented his research work on the use of new technologies to improve motor recovery after a...

Bassem Hassan’s team at VIB/KU Leuven has discovered a previously unknown mechanism that is highly conserved between species and which regulates neurogenesis through precise temporal control of the activity of a family of proteins essential for brain...

Guido Gerig is Institute Professor at the Computer Science and Engineering Department of the NYU’s Tandon School of Engineering. Here, he gives us a glimpse at longitudinal neuroimagery, which allows doctors to follow patient progress over time.

Paris Brain Institute brings together in one place patients, doctors and researchers in order to rapidly develop treatments for nerve damage and apply these to patients as soon as possible. Coming from all backgrounds and countries, the best...

Nikos K. Logothetis is a neuroscience professor at the Max Planck Institute and visited the Institut du Cerveau - ICM on December 14, 2015. In this interview, he explains how the NET-fMRI technique works, allowing scientists to record communications...

Patients with fronto-temporal dementia need specific and appropriate medical care. However, this disease is still too often confused with Alzheimer's disease. Clinicians and researchers from Paris Brain Institute and from the Memory and Alzheimer's...

Fiona Doetsch is a research group leader at the Biozentrum of the University of Basel. Upon her visit at the Institut du Cerveau - ICM, she presented her work on stem cells, and more specifically, on what triggers their activation. Stem cells could...

The Institut du Cerveau - ICM scientists have recently discovered a mechanism which protects neurons from cell death. The loss of this protective mechanism may contribute to the degeneration of neurons in patients with Parkinson's disease.

Yves Agid's forum, neurologist and founding member of the Institut du Cerveau - ICM, after the symposium on the History of FENS-Institut du Cerveau - ICM Neuroscience, on December 3 and 4, 2015.

The majority of neurodegenerative disorders, from Alzheimer's disease to amyotrophic lateral sclerosis to Parkinson's disease, share common features with prion diseases.